Mexico approves Oxford/AstraZeneca vaccine
A COVID-19 vaccine developed by England's University of Oxford and British-Swedish pharmaceutical giant AstraZeneca has been authorized for emergency use in Mexico.
Mexico's Federal Commission for the Protection against Sanitary Risks (COFEPRIS), a decentralized regulatory body of the country's health ministry, announced its decision to approve the shot in a statement Monday evening.
Mexican Secretary of Foreign Relations Marcelo Ebrard took to Twitter to praise the approval, calling it "very good news."
It's the second COVID-19 vaccine to be approved in the Latin American nation. Mexico authorized a vaccine developed by U.S. pharmaceutical company Pfizer and its German partner BioNTech for emergency use on Dec. 11, just before the United States did so as well.
Mexico has reported more than 1.4 million confirmed cases of COVID-19 since the start of the pandemic, including at least 127,757 deaths, according to a real-time count kept by Johns Hopkins University.